Morie Gertz

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Gertz Morie A; Abonour Rafat; Heffner Leonard T; Greipp Philip R; Uno Hajime; Rajkumar S V
Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial.
Lacy Martha Q; Hayman Suzanne R; Gertz Morie A; Dispenzieri Angela; Buadi Francis; Kumar Shaji; Greipp Philip R; Lust John A; Russell Stephen J; Dingli David; Kyle Robert A; Fonseca Rafael; Bergsagel P Leif; Roy Vivek; Mikhael Joseph R; Stewart A Keith; Laumann Kristina; Allred Jacob B; Mandrekar Sumithra J; Rajkumar S Vincent
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma.
Gertz Morie A; Leung Nelson; Lacy Martha Q; Dispenzieri Angela; Zeldenrust Steven R; Hayman Suzanne R; Buadi Francis K; Dingli David; Greipp Philip R; Kumar Shaji K; Lust John A; Rajkumar S Vincent; Russell Stephen J; Witzig Thomas E
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Morie Gertz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Gertz Morie A; Abonour Rafat; Heffner Leonard T; Greipp Philip R; Uno Hajime; Rajkumar S V
Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial.
British journal of haematology 2009;147(5):677-80.
2009: Lacy Martha Q; Hayman Suzanne R; Gertz Morie A; Dispenzieri Angela; Buadi Francis; Kumar Shaji; Greipp Philip R; Lust John A; Russell Stephen J; Dingli David; Kyle Robert A; Fonseca Rafael; Bergsagel P Leif; Roy Vivek; Mikhael Joseph R; Stewart A Keith; Laumann Kristina; Allred Jacob B; Mandrekar Sumithra J; Rajkumar S Vincent
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(30):5008-14.
2009: Gertz Morie A; Leung Nelson; Lacy Martha Q; Dispenzieri Angela; Zeldenrust Steven R; Hayman Suzanne R; Buadi Francis K; Dingli David; Greipp Philip R; Kumar Shaji K; Lust John A; Rajkumar S Vincent; Russell Stephen J; Witzig Thomas E
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(10):3132-7.
2009: Chee Cheng E; Kumar Shaji; Larson Dirk R; Kyle Robert A; Dispenzieri Angela; Gertz Morie A; Colby Colin L; Rajkumar S Vincent
The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma.
Blood 2009;114(13):2617-8.
2009: Fatema Kaniz; Gertz Morie A; Barnes Marion E; Eisinger Amy D; Ness Sue Ann C; Gersh Bernard J; Micallef Ivana N M; Seward James B; Cha Stephen S; Bailey Kent R; Tsang Teresa S M
Acute weight gain and diastolic dysfunction as a potent risk complex for post stem cell transplant atrial fibrillation.
American journal of hematology 2009;84(8):499-503.
2009: Kapoor Prashant; Kumar Shaji; Fonseca Rafael; Lacy Martha Q; Witzig Thomas E; Hayman Suzanne R; Dispenzieri Angela; Buadi Francis; Bergsagel P Leif; Gertz Morie A; Dalton Robert J; Mikhael Joseph R; Dingli David; Reeder Craig B; Lust John A; Russell Stephen J; Roy Vivek; Zeldenrust Steven R; Stewart A Keith; Kyle Robert A; Greipp Philip R; Rajkumar S Vincent
Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone.
Blood 2009;114(3):518-21.
2009: Sadek Ibrahim; Dispenzieri Angela; Gertz Morie A; Kumar Shaji
Activity of bortezomib administered once every 3 weeks for treatment of relapsed multiple myeloma.
Leukemia & lymphoma 2009;50(6):1033-5.
2009: Feng DaLi; Syed Imran S; Martinez Matthew; Oh Jae K; Jaffe Allan S; Grogan Martha; Edwards William D; Gertz Morie A; Klarich Kyle W
Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis.
Circulation 2009;119(18):2490-7.
2009: Costa Luciano J; Kumar Shaji; Dispenzieri Angela; Hayman Suzanne E; Buadi Francis K; Dingli David; Litzow Mark R; Gertz Morie A; Lacy Martha Q
Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma.
Leukemia & lymphoma 2009;50(5):781-7.
2009: Gertz Morie A
Is antisense nonsense?
Leukemia & lymphoma 2009;50(4):519-20.
2009: Gertz M A; Kumar S K; Lacy M Q; Dispenzieri A; Hayman S R; Buadi F K; Dingli D; Gastineau D A; Winters J L; Litzow M R
Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma.
Bone marrow transplantation 2009;43(8):619-25.
2009: Gertz Morie A; Hayman Suzanne R; Buadi Francis K
Transplantation for IgM amyloidosis and IgM myeloma.
Clinical lymphoma & myeloma 2009;9(1):77-9.
2009: Gertz Morie A
Caring for the terminally ill patient with hematologic malignancies.
Leukemia & lymphoma 2009;50(3):313-4.
2009: Bryce Alan H; Ketterling Rhett P; Gertz Morie A; Lacy Martha; Knudson Ryan A; Zeldenrust Steven; Kumar Shaji; Hayman Suzanne; Buadi Francis; Kyle Robert A; Greipp Philip R; Lust John A; Russell Stephen; Rajkumar S Vincent; Fonseca Rafael; Dispenzieri Angela
Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.
Haematologica 2009;94(3):380-6.
2009: Lust John A; Lacy Martha Q; Zeldenrust Steven R; Dispenzieri Angela; Gertz Morie A; Witzig Thomas E; Kumar Shaji; Hayman Suzanne R; Russell Stephen J; Buadi Francis K; Geyer Susan M; Campbell Megan E; Kyle Robert A; Rajkumar S Vincent; Greipp Philip R; Kline Michael P; Xiong Yuning; Moon-Tasson Laurie L; Donovan Kathleen A
Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component.
Mayo Clinic proceedings. Mayo Clinic 2009;84(2):114-22.
2009: Gertz Morie A; Buadi Francis K
Does stem cell transplantation have a role in the management of multiple myeloma, 2009?
Expert opinion on pharmacotherapy 2009;10(1):1-4.
2009: Gertz Morie A; Ghobrial Irene; Luc-Harousseau Jean
Multiple myeloma: biology, standard therapy, and transplant therapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(1 Suppl):46-52.
2009: Dimopoulos Meletios Athanasios; Gertz Morie A; Kastritis Efstathios; Garcia-Sanz Ramon; Kimby Eva K; Leblond Veronique; Fermand Jean-Paul; Merlini Giampaolo; Morel Pierre; Morra Enrica; Ocio Enrique M; Owen Roger; Ghobrial Irene M; Seymour John; Kyle Robert A; Treon Steven P
Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(1):120-6.
2009: Dhodapkar Madhav V; Hoering Antje; Gertz Morie A; Rivkin Saul; Szymonifka Jackie; Crowley John; Barlogie Bart
Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group-directed intergroup trial S9003.
Blood 2009;113(4):793-6.
2009: Sideras Kostandinos; Gertz Morie A
Amyloidosis.
Advances in clinical chemistry 2009;47():1-44.
2008: Gertz Morie A
New targets and treatments in multiple myeloma: Src family kinases as central regulators of disease progression.
Leukemia & lymphoma 2008;49(12):2240-5.
2008: Cavo Michele; Attal Michel; Gertz Morie A; Giralt Sergio; Ludwig Heinz; Morgan Gareth J; Anderson Kenneth C
The current landscape of multiple myeloma treatment.
Leukemia research 2008;32 Suppl 1():S1-24.
2008: Soares Sandra M; Fervenza Fernando C; Lager Donna J; Gertz Morie A; Cosio Fernando G; Leung Nelson
Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2008;52(6):1079-83.
2008: Gertz Morie A; Koka Sreenivas
The dilemma of jaw osteonecrosis in patients with multiple myeloma.
Leukemia & lymphoma 2008;49(11):2037-9.
2008: Bryce Alan H; Ketterling Rhett P; Gertz Morie A; Lacy Martha; Knudson Ryan A; Kumar Shaji; Kyle Robert A; Fonseca Rafael; Greipp Phillip R; Lust John A; Rajkumar Vincent S; Hayman Suzanne R; Buadi Francis; Russell Stephen J; Zeldenrust Stephen R; Dispenzieri Angela
A novel report of cig-FISH and cytogenetics in POEMS syndrome.
American journal of hematology 2008;83(11):840-1.
2008: Gertz Morie A; Ansell Stephen M; Dingli David; Dispenzieri Angela; Buadi Francis K; Elliott Michelle A; Gastineau Dennis A; Hayman Suzanne R; Hogan William J; Inwards David J; Johnston Patrick B; Kumar Shaji; Lacy Martha Q; Leung Nelson; Micallef Ivana N M; Porrata Luis F; Schafer Barbara A; Wolf Robert C; Litzow Mark R
Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative.
Mayo Clinic proceedings. Mayo Clinic 2008;83(10):1131-8.
2008: Costa L J; Rodriguez V; Porrata L F; Lacy M Q; Elliott M A; Gertz M A; Gastineau D A; Litzow M R
Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy.
Bone marrow transplantation 2008;42(7):497-8.
2008: Malhotra Pankaj; Hogan William J; Litzow Mark R; Elliott Michelle A; Gastineau Dennis A; Ansell Stephen M; Dispenzieri Angela; Gertz Morie A; Hayman Suzanne R; Inwards David J; Lacy Martha Q; Micallef Ivana N; Porrata Luis F; Tefferi Ayalew
Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 years.
Leukemia & lymphoma 2008;49(9):1724-30.
2008: Gertz Morie A; Lacy Martha Q; Lust John A; Greipp Philip R; Witzig Thomas E; Kyle Robert A
Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosis.
Haematologica 2008;93(9):1402-6.
2008: Kumar S; Mahmood S T; Lacy M Q; Dispenzieri A; Hayman S R; Buadi F K; Dingli D; Rajkumar S V; Litzow M R; Gertz M A
Impact of early relapse after auto-SCT for multiple myeloma.
Bone marrow transplantation 2008;42(6):413-20.
2008: Vijay Arun; Gertz Morie A
Current treatment options for Waldenström macroglobulinemia.
Clinical lymphoma & myeloma 2008;8(4):219-29.
2008: Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R; Kumar Shaji; Kyle Robert A; Rajkumar S Vincent; Edwards Brooks S; Rodeheffer Richard J; Frantz Robert P; Kushwaha Sudhir S; Clavell Alfredo L; Dearani Joseph A; Sundt Thoralf M; Daly Richard C; McGregor Christopher G A; Gastineau Dennis A; Litzow Mark R; Gertz Morie A
Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2008;27(8):823-9.
2008: Kumar Shaji K; Dingli David; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R; Buadi Francis K; Rajkumar S Vincent; Litzow Mark R; Gertz Morie A
Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis.
American journal of hematology 2008;83(8):614-7.
2008: Leleu Xavier; Moreau Anne-Sophie; Weller Edie; Roccaro Aldo M; Coiteux ValéRie; Manning Robert; Nelson Marybeth; Leduc Renee; Robu Daniela; Dupire Sophie; Hatjiharissi Evdoxia; Burwick Nicholas; Darre Stéphane; Hennache Bernadette; Treon Steven P; Facon Thierry; Gertz Morie A; Ghobrial Irene M
Serum immunoglobulin free light chain correlates with tumor burden markers in Waldenstrom macroglobulinemia.
Leukemia & lymphoma 2008;49(6):1104-7.
2008: Ege Hilmi; Gertz Morie A; Markovic Svetomir N; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R; Kumar Shaji K; Porrata Luis F
Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study.
British journal of haematology 2008;141(6):792-8.
2008: Leung N; Gertz M A; Zeldenrust S R; Rajkumar S V; Dispenzieri A; Fervenza F C; Kumar S; Lacy M Q; Lust J A; Greipp P R; Witzig T E; Hayman S R; Russell S J; Kyle R A; Winters J L
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains.
Kidney international 2008;73(11):1282-8.
2008: Kumar S K; Dingli D; Dispenzieri A; Lacy M Q; Hayman S R; Buadi F K; Rajkumar S V; Litzow M R; Gertz M A
Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCT.
Bone marrow transplantation 2008;41(12):1013-9.
2008: Lorenz Elizabeth C; Gertz Morie A; Fervenza Fernando C; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne R; Gastineau Dennis A; Leung Nelson
Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(6):2052-7.
2008: Gertz Morie A
Current therapy of myeloma induced renal failure.
Leukemia & lymphoma 2008;49(5):833-4.
2008: Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne R; Kumar Shaji K; Buadi Francis; Dingli David; Litzow Mark R; Gastineau Dennis A; Inwards David J; Elliott Michelle A; Micallef Ivana N; Ansell Stephen M; Hogan William J; Porrata Luis F; Johnston Patrick A; Afessa Bekele; Bryce Alan; Kyle Robert A; Gertz Morie A
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome.
European journal of haematology 2008;80(5):397-406.
2008: Tiedemann R E; Gonzalez-Paz N; Kyle R A; Santana-Davila R; Price-Troska T; Van Wier S A; Chng W J; Ketterling R P; Gertz M A; Henderson K; Greipp P R; Dispenzieri A; Lacy M Q; Rajkumar S V; Bergsagel P L; Stewart A K; Fonseca R
Genetic aberrations and survival in plasma cell leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(5):1044-52.
2008: Kumar Shaji K; Dingli David; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R; Buadi Francis K; Rajkumar S Vincent; Litzow Mark R; Gertz Morie A
Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders.
British journal of haematology 2008;141(2):205-11.
2008: Lonial Sagar; Gertz Morie A
Eliminating the complete response penalty from myeloma response assessment.
Blood 2008;111(6):3297-8.
2008: Kumar Shaji; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne R; Leung Nelson; Zeldenrust Steve R; Buadi Francis K; Kyle Robert A; Rajkumar S Vincent; Gertz Morie A
Serum uric acid: novel prognostic factor in primary systemic amyloidosis.
Mayo Clinic proceedings. Mayo Clinic 2008;83(3):297-303.
2008: Kumar Shaji K; Rajkumar S Vincent; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne R; Buadi Francis K; Zeldenrust Steven R; Dingli David; Russell Stephen J; Lust John A; Greipp Philip R; Kyle Robert A; Gertz Morie A
Improved survival in multiple myeloma and the impact of novel therapies.
Blood 2008;111(5):2516-20.
2008: Gertz Morie A
Troponin in hematologic oncology.
Leukemia & lymphoma 2008;49(2):194-203.
2008: Kumar Shaji; Dispenzieri Angela; Gertz Morie A
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.
The New England journal of medicine 2008;358(1):91; author reply 92-3.
2008: Dispenzieri Angela; Kyle Robert A; Katzmann Jerry A; Therneau Terry M; Larson Dirk; Benson Joanne; Clark Raynell J; Melton L Joseph; Gertz Morie A; Kumar Shaji K; Fonseca Rafael; Jelinek Diane F; Rajkumar S Vincent
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma.
Blood 2008;111(2):785-9.
2007: Gertz Morie A
What is the correct philosophy for the treatment of multiple myeloma?
Leukemia & lymphoma 2007;48(12):2298-9.
2007: Feng DaLi; Edwards William D; Oh Jae K; Chandrasekaran Krishnaswamy; Grogan Martha; Martinez Matthew W; Syed Imran S; Hughes Deborah A; Lust John A; Jaffe Allan S; Gertz Morie A; Klarich Kyle W
Intracardiac thrombosis and embolism in patients with cardiac amyloidosis.
Circulation 2007;116(21):2420-6.
2007: Dingli David; Pacheco Jorge M; Nowakowski Grzegorz S; Kumar Shaji K; Dispenzieri Angela; Hayman Suzanne R; Lacy Martha Q; Gastineau Dennis A; Gertz Morie A
Relationship between depth of response and outcome in multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4933-7.
2007: Gertz M A; Lacy M Q; Dispenzieri A; Hayman S R; Kumar S K; Leung N; Gastineau D A
Transplantation without growth factor: engraftment kinetics after stem cell transplantation for primary systemic amyloidosis (AL).
Bone marrow transplantation 2007;40(10):989-93.
2007: Rajkumar S Vincent; Richardson Paul G; Lacy Martha Q; Dispenzieri Angela; Greipp Philip R; Witzig Thomas E; Schlossman Robert; Sidor Carolyn F; Anderson Kenneth C; Gertz Morie A
Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(20):6162-7.
2007: Lacy Martha Q; Gertz Morie A; Dispenzieri Angela; Hayman Suzanne R; Geyer Susan; Kabat Brian; Zeldenrust Steven R; Kumar Shaji; Greipp Philip R; Fonseca Rafael; Lust John A; Russell Stephen J; Kyle Robert A; Witzig Thomas E; Bergsagel P Leif; Stewart A Keith; Rajkumar S Vincent
Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma.
Mayo Clinic proceedings. Mayo Clinic 2007;82(10):1179-84.
2007: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R; Kumar Shaji K; Leung Nelson; Gastineau Dennis A
Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: importance of achieving a complete response.
Haematologica 2007;92(10):1415-8.
2007: Kumar S; Dispenzieri A; Lacy M Q; Hayman S R; Buadi F K; Gastineau D A; Litzow M R; Fonseca R; Roy V; Rajkumar S V; Gertz M A
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(9):2035-42.
2007: Gertz Morie A
Management of cold haemolytic syndrome.
British journal of haematology 2007;138(4):422-9.
2007: Dingli David; Pacheco Jorge M; Dispenzieri Angela; Hayman Suzanne R; Kumar Shaji K; Lacy Martha Q; Gastineau Dennis A; Gertz Morie A
Serum M-spike and transplant outcome in patients with multiple myeloma.
Cancer science 2007;98(7):1035-40.
2007: Rajkumar S Vincent; Gertz Morie A
Advances in the treatment of amyloidosis.
The New England journal of medicine 2007;356(23):2413-5.
2007: Vijay Arun; Gertz Morie A
Waldenström macroglobulinemia.
Blood 2007;109(12):5096-103.
2007: Leung Nelson; Dispenzieri Angela; Lacy Martha Q; Kumar Shaji K; Hayman Suzanne R; Fervenza Fernando C; Cha Stephen S; Gertz Morie A
Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(3):440-4.
2007: Gertz M A; Lacy M Q; Dispenzieri A; Hayman S R; Kumar S; Leung N; Gastineau D A
Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma.
Bone marrow transplantation 2007;39(10):605-11.
2007: Dingli David; Pacheco Jorge M; Dispenzieri Angela; Hayman Suzanne R; Kumar Shaji K; Lacy Martha Q; Gastineau Dennis A; Gertz Morie A
In vivo and in silico studies on single versus multiple transplants for multiple myeloma.
Cancer science 2007;98(5):734-9.
2007: Hatjiharissi Evdoxia; Ngo Hai; Leontovich Alexey A; Leleu Xavier; Timm Michael; Melhem Mona; George Diane; Lu Ganwei; Ghobrial Joanna; Alsayed Yazan; Zeismer Steven; Cabanela Miguel; Nehme Alex; Jia Xiaoying; Moreau Anne Sophie; Treon Steven P; Fonseca Rafael; Gertz Morie A; Anderson Kenneth C; Witzig Thomas E; Ghobrial Irene M
Proteomic analysis of waldenstrom macroglobulinemia.
Cancer research 2007;67(8):3777-84.
2007: Modesto Karen M; Dispenzieri Angela; Gertz Morie; Cauduro Sanderson A; Khandheria Bijoy K; Seward James B; Kyle Robert; Wood Christina M; Bailey Kent R; Tajik Abdel Jamil; Miller Fletcher A; Pellikka Patricia A; Abraham Theodore P
Vascular abnormalities in primary amyloidosis.
European heart journal 2007;28(8):1019-24.
2007: Chng Wee J; Kumar Shaji; Vanwier Scott; Ahmann Greg; Price-Troska Tammy; Henderson Kim; Chung Tae-Hoon; Kim Seungchan; Mulligan George; Bryant Barbara; Carpten John; Gertz Morie; Rajkumar S Vincent; Lacy Martha; Dispenzieri Angela; Kyle Robert; Greipp Philip; Bergsagel P Leif; Fonseca Rafael
Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling.
Cancer research 2007;67(7):2982-9.
2007: Koka Sreenivas; Clarke Bart L; Amin Shreyasee; Gertz Morie; Ruggiero Salvatore L
Oral bisphosphonate therapy and osteonecrosis of the jaw: what to tell the concerned patient.
The International journal of prosthodontics 2007;20(2):115-22.
2007: Gertz Morie A
Relevant prognostic features of multiple myeloma and the new International Staging System.
Leukemia & lymphoma 2007;48(3):458-68.
2007: Dispenzieri Angela; Rajkumar S Vincent; Gertz Morie A; Fonseca Rafael; Lacy Martha Q; Bergsagel P Leif; Kyle Robert A; Greipp Philip R; Witzig Thomas E; Reeder Craig B; Lust John A; Russell Stephen J; Hayman Suzanne R; Roy Vivek; Kumar Shaji; Zeldenrust Steven R; Dalton Robert J; Stewart A Keith
Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement.
Mayo Clinic proceedings. Mayo Clinic 2007;82(3):323-41.
2007: Wittich Christopher M; Neben-Wittich Michelle A; Mueller Paul S; Gertz Morie A; Edwards William D
Deposition of amyloid proteins in the epicardial coronary arteries of 58 patients with primary systemic amyloidosis.
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2007;16(2):75-8.
2007: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R; Kumar Shaji
Transplantation for amyloidosis.
Current opinion in oncology 2007;19(2):136-41.
2007: Stewart A K; Bergsagel P L; Greipp P R; Dispenzieri A; Gertz M A; Hayman S R; Kumar S; Lacy M Q; Lust J A; Russell S J; Witzig T E; Zeldenrust S R; Dingli D; Reeder C B; Roy V; Kyle R A; Rajkumar S V; Fonseca R
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(3):529-34.
2007: Gertz Morie A
Managing myeloma of the kidney.
Leukemia & lymphoma 2007;48(2):221-2.
2007: Gonzalez-Paz Natalia; Chng Wee J; McClure Rebecca F; Blood Emily; Oken Martin M; Van Ness Brian; James C David; Kurtin Paul J; Henderson Kimberly; Ahmann Gregory J; Gertz Morie; Lacy Martha; Dispenzieri Angela; Greipp Philip R; Fonseca Rafael
Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications.
Blood 2007;109(3):1228-32.
2007: Gertz Morie A
Managing plasma cell leukemia.
Leukemia & lymphoma 2007;48(1):5-6.
2007: Siddiqui Mustaqeem A; Gertz Morie; Dean Diana
Amyloid goiter as a manifestation of primary systemic amyloidosis.
Thyroid : official journal of the American Thyroid Association 2007;17(1):77-80.
2007: Ocio E M; Schop R F J; Gonzalez B; Van Wier S A; Hernandez-Rivas J M; Gutierrez N C; Garcia-Sanz R; Moro M J; Aguilera C; Hernandez J; Xu R; Greipp P R; Dispenzieri A; Jalal S M; Lacy M Q; Gonzalez-Paz N; Gertz M A; San Miguel J F; Fonseca R
6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis.
British journal of haematology 2007;136(1):80-6.
2007: Hemmer Patrick R; Topazian Mark D; Gertz Morie A; Abraham Susan C
Globular amyloid deposits isolated to the small bowel: a rare association with AL amyloidosis.
The American journal of surgical pathology 2007;31(1):141-5.
2007: Abraham Roshini S; Manske Michelle K; Zuckerman Neta S; Sohni Abhishek; Edelman Hanna; Shahaf Gitit; Timm Michael M; Dispenzieri Angela; Gertz Morie A; Mehr Ramit
Novel analysis of clonal diversification in blood B cell and bone marrow plasma cell clones in immunoglobulin light chain amyloidosis.
Journal of clinical immunology 2007;27(1):69-87.
2007: Dispenzieri Angela; Lacy Martha Q; Zeldenrust Steven R; Hayman Suzanne R; Kumar Shaji K; Geyer Susan M; Lust John A; Allred Jacob B; Witzig Thomas E; Rajkumar S Vincent; Greipp Philip R; Russell Stephen J; Kabat Brian; Gertz Morie A
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis.
Blood 2007;109(2):465-70.
2006: Fonseca R; Van Wier S A; Chng W J; Ketterling R; Lacy M Q; Dispenzieri A; Bergsagel P L; Rajkumar S V; Greipp P R; Litzow M R; Price-Troska T; Henderson K J; Ahmann G J; Gertz M A
Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(11):2034-40.
2006: Chng Wee J; Schop Roelandt F; Price-Troska Tammy; Ghobrial Irene; Kay Neil; Jelinek Diane F; Gertz Morie A; Dispenzieri Angela; Lacy Martha; Kyle Robert A; Greipp Philip R; Tschumper Renee C; Fonseca Rafael; Bergsagel Peter Leif
Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma.
Blood 2006;108(8):2755-63.
2006: Bryce Alan H; Dispenzieri Angela; Kyle Robert A; Lacy Martha Q; Rajkumar S Vincent; Inwards David J; Yasenchak Christopher A; Kumar Shaji K; Gertz Morie A
Response to rituximab in patients with type II cryoglobulinemia.
Clinical lymphoma & myeloma 2006;7(2):140-4.
2006: Schop Roelandt F J; Van Wier Scott A; Xu Ruifang; Ghobrial Irene; Ahmann Gregory J; Greipp Philip R; Kyle Robert A; Dispenzieri Angela; Lacy Martha Q; Rajkumar S Vincent; Gertz Morie A; Fonseca Rafael
6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
Cancer genetics and cytogenetics 2006;169(2):150-3.
2006: Dingli David; Kyle Robert A; Rajkumar S Vincent; Nowakowski Grzegorz S; Larson Dirk R; Bida John P; Gertz Morie A; Therneau Terry M; Melton L Joseph; Dispenzieri Angela; Katzmann Jerry A
Immunoglobulin free light chains and solitary plasmacytoma of bone.
Blood 2006;108(6):1979-83.
2006: Gertz Morie A
When is myeloma, myeloma?
Leukemia & lymphoma 2006;47(8):1452-3.
2006: Lacy Martha Q; Dispenzieri Angela; Gertz Morie A; Greipp Philip R; Gollbach Kimberly L; Hayman Suzanne R; Kumar Shaji; Lust John A; Rajkumar S Vincent; Russell Stephen J; Witzig Thomas E; Zeldenrust Steven R; Dingli David; Bergsagel P Lief; Fonseca Rafael; Reeder Craig B; Stewart A Keith; Roy Vivek; Dalton Robert J; Carr Alan B; Kademani Deepak; Keller Eugene E; Viozzi Christopher F; Kyle Robert A
Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2006;81(8):1047-53.
2006: Anagnostopoulos Athanasios; Hari Parameswaran N; Pérez Waleska S; Ballen Karen; Bashey Asad; Bredeson Christopher N; Freytes César O; Gale Robert Peter; Gertz Morie A; Gibson John; Goldschmidt Hartmut; Lazarus Hillard M; McCarthy Philip L; Reece Donna E; Vesole David H; Giralt Sergio A
Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(8):845-54.
2006: Modesto Karen M; Cauduro Sanderson; Dispenzieri Angela; Khandheria Bijoy; Belohlavek Marek; Lysyansky Peter; Friedman Zvi; Gertz Morie; Abraham Theodore P
Two-dimensional acoustic pattern derived strain parameters closely correlate with one-dimensional tissue Doppler derived strain measurements.
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2006;7(4):315-21.
2006: Gertz Morie A
Autologous attack on amyloidosis.
Mayo Clinic proceedings. Mayo Clinic 2006;81(7):874-6.
2006: Bryce Alan H; Kyle Robert A; Dispenzieri Angela; Gertz Morie A
Natural history and therapy of 66 patients with mixed cryoglobulinemia.
American journal of hematology 2006;81(7):511-8.
2006: Manske Michelle K; Zuckerman Neta S; Timm Michael M; Maiden Stephanie; Edelman Hanna; Shahaf Gitit; Barak Michal; Dispenzieri Angela; Gertz Morie A; Mehr Ramit; Abraham Roshini S
Quantitative analysis of clonal bone marrow CD19+ B cells: use of B cell lineage trees to delineate their role in the pathogenesis of light chain amyloidosis.
Clinical immunology (Orlando, Fla.) 2006;120(1):106-20.
2006: Anakwenze Okechukwu A; Lerman Amir; Edwards William D; Gertz Morie A; Rihal Charanjit S
Death during coronary angiography in a woman with cardiac amyloidosis.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2006;13(2):108-10.
2006: Valente Maria; Roy Vivek; Lacy Martha Q; Dispenzieri Angela; Gertz Morie A
Autologous stem cell transplantation and IgM amyloidosis.
Leukemia & lymphoma 2006;47(6):1006-12.
2006: Buadi F K; Micallef I N; Ansell S M; Porrata L F; Dispenzieri A; Elliot M A; Gastineau D A; Gertz M A; Lacy M Q; Litzow M R; Tefferi A; Inwards D J
Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma.
Bone marrow transplantation 2006;37(11):1017-22.
2006: Elliott M A; Tefferi A; Hogan W J; Letendre L; Gastineau D A; Ansell S M; Dispenzieri A; Gertz M A; Hayman S R; Inwards D J; Lacy M Q; Micallef I N; Porrata L F; Litzow M R
Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia.
Bone marrow transplantation 2006;37(11):1003-8.
2006: Gertz Morie A
Managing monoclonal gammopathy-associated neuropathy.
Leukemia & lymphoma 2006;47(5):785-6.
2006: Chng W J; Santana-Dávila R; Van Wier S A; Ahmann G J; Jalal S M; Bergsagel P L; Chesi M; Trendle M C; Jacobus S; Blood E; Oken M M; Henderson K; Kyle R A; Gertz M A; Lacy M Q; Dispenzieri A; Greipp P R; Fonseca R
Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(5):807-13.
2006: Treon Steven P; Gertz Morie A; Dimopoulos Meletios; Anagnostopoulos Athanasios; Blade Joan; Branagan Andrew R; Garcia-Sanz Ramon; Johnson Stephen; Kimby Eva; Leblond Veronique; Fermand Jean-Paul; Maloney David G; Merlini Giampaolo; Morel Pierre; Morra Enrica; Nichols Gwen; Ocio Enrique M; Owen Roger; Stone Marvin J
Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia.
Blood 2006;107(9):3442-6.
2006: Chng Wee J; Ahmann Greg J; Henderson Kim; Santana-Davila Rafael; Greipp Philip R; Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Kumar Shaji; Rajkumar S Vincent; Lust John A; Kyle Robert A; Zeldenrust Steven R; Hayman Suzanne R; Fonseca Rafael
Clinical implication of centrosome amplification in plasma cell neoplasm.
Blood 2006;107(9):3669-75.
2006: Ghobrial Irene M; Fonseca Rafael; Gertz Morie A; Plevak Matthew F; Larson Dirk R; Therneau Terry M; Wolf Robert C; Hoffmann Randi J; Lust John A; Witzig Thomas E; Lacy Martha Q; Dispenzieri Angela; Vincent Rajkumar S; Zeldenrust Stephen R; Greipp Philip R; Kyle Robert A
Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia.
British journal of haematology 2006;133(2):158-64.
2006: Gertz Morie A
Cold agglutinin disease.
Haematologica 2006;91(4):439-41.
2006: Dispenzieri Angela; Lacy Martha Q; Katzmann Jerry A; Rajkumar S Vincent; Abraham Roshini S; Hayman Suzanne R; Kumar Shaji K; Clark Raynell; Kyle Robert A; Litzow Mark R; Inwards David J; Ansell Stephen M; Micallef Ivana M; Porrata Luis F; Elliott Michelle A; Johnston Patrick B; Greipp Philip R; Witzig Thomas E; Zeldenrust Steven R; Russell Stephen J; Gastineau Dennis; Gertz Morie A
Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.
Blood 2006;107(8):3378-83.
2006: Dingli David; Nowakowski Grzegorz S; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne R; Rajkumar S Vincent; Greipp Philip R; Litzow Mark R; Gastineau Dennis A; Witzig Thomas E; Gertz Morie A
Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system.
Blood 2006;107(8):3384-8.
2006: Halligan Christine S; Lacy Martha Q; Vincent Rajkumar S; Dispenzieri Angela; Witzig Thomas E; Lust John A; Fonseca Rafael; Gertz Morie A; Kyle Robert A; Pruthi Rajiv K
Natural history of thromboembolism in AL amyloidosis.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2006;13(1):31-6.
2006: Dingli David; Nowakowski Grzegorz S; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne; Litzow Mark R; Gastineau Dennis A; Gertz Morie A
Cyclophosphamide mobilization does not improve outcome in patients receiving stem cell transplantation for multiple myeloma.
Clinical lymphoma & myeloma 2006;6(5):384-8.
2006: Kimby Eva; Treon Steven P; Anagnostopoulos Athanasios; Dimopoulos Meletios; Garcia-Sanz Ramon; Gertz Morie A; Johnson Stephen; LeBlond Veronique; Fermand Jean-Paul; Maloney David G; Merlini Giampaolo; Morel Pierre; Morra Enrica; Nichols Gwen; Ocio Enrique M; Owen Roger; Stone Marvin; Bladé Joan
Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia.
Clinical lymphoma & myeloma 2006;6(5):380-3.
2006: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R; Kumar Shaji K
High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
Expert review of anticancer therapy 2006;6(3):343-60.
2006: Dispenzieri Angela; Gertz Morie A; Lacy Martha Q; Geyer Susan M; Fitch Tom R; Fenton Robert G; Fonseca Rafael; Isham Crescent R; Ziesmer Steven C; Erlichman Charles; Bible Keith C
Flavopiridol in patients with relapsed or refractory multiple myeloma: a phase 2 trial with clinical and pharmacodynamic end-points.
Haematologica 2006;91(3):390-3.
2006: Chng W J; Winkler J M; Greipp P R; Jalal S M; Bergsagel P L; Chesi M; Trendle M C; Ahmann G J; Henderson K; Blood E; Oken M M; Hulbert A; Van Wier S A; Santana-Dávila R; Kyle R A; Gertz M A; Lacy M Q; Dispenzieri A; Fonseca R
Ploidy status rarely changes in myeloma patients at disease progression.
Leukemia research 2006;30(3):266-71.
2006: Xiong Yuning; Donovan Kathleen A; Kline Michael P; Gornet Michael K; Moon-Tasson Laurie L; Lacy Martha Q; Dispenzieri Angela; Gertz Morie A; Greipp Philip R; Lust John A
Identification of two groups of smoldering multiple myeloma patients who are either high or low producers of interleukin-1.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2006;26(2):83-95.
2006: Dispenzieri Angela; Gertz Morie A; Lacy Martha Q; Geyer Susan M; Greipp Phillip R; Rajkumar S Vincent; Kimlinger Teresa; Lust John A; Fonseca Rafael; Allred Jacob; Witzig Thomas E
A phase II trial of imatinib in patients with refractory/relapsed myeloma.
Leukemia & lymphoma 2006;47(1):39-42.
2006: Gertz Morie A
Cold hemolytic syndrome.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2006;():19-23.
2005: Gertz Morie A
Managing myeloma kidney.
Annals of internal medicine 2005;143(11):835-7.
2005: Dingli David; Rajkumar S Vincent; Nowakowski Grzegorz S; Gertz Morie A; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne; Fonseca Rafael; Lust John A; Kyle Robert A; Greipp Philip R; Witzig Thomas E
Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial.
Haematologica 2005;90(12):1650-4.
2005: Rajkumar S Vincent; Hayman Suzanne R; Lacy Martha Q; Dispenzieri Angela; Geyer Susan M; Kabat Brian; Zeldenrust Steven R; Kumar Shaji; Greipp Philip R; Fonseca Rafael; Lust John A; Russell Stephen J; Kyle Robert A; Witzig Thomas E; Gertz Morie A
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma.
Blood 2005;106(13):4050-3.
2005: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R
Amyloidosis: diagnosis and management.
Clinical lymphoma & myeloma 2005;6(3):208-19.
2005: Neben-Wittich Michelle A; Wittich Christopher M; Mueller Paul S; Larson Dirk R; Gertz Morie A; Edwards William D
Obstructive intramural coronary amyloidosis and myocardial ischemia are common in primary amyloidosis.
The American journal of medicine 2005;118(11):1287.
2005: Leung Nelson; Leung Tessa R; Cha Stephen S; Dispenzieri Angela; Lacy Martha Q; Gertz Morie A
Excessive fluid accumulation during stem cell mobilization: a novel prognostic factor of first-year survival after stem cell transplantation in AL amyloidosis patients.
Blood 2005;106(10):3353-7.
2005: Lacy Martha Q; Hogan William J; Gertz Morie A; Dispenzieri Angela; Rajkumar S Vincent; Hayman Suzanne; Kumar Shaji; Litzow Mark R; Schroeter Arnold L
Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation.
Archives of dermatology 2005;141(10):1277-82.
2005: Gertz Morie A; Leung Nelson; Lacy Martha Q; Dispenzieri Angela
Myeloablative chemotherapy and stem cell transplantation in myeloma or primary amyloidosis with renal involvement.
Kidney international 2005;68(4):1464-71.
2005: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Greipp Philip R; Litzow Mark R; Henderson Kimberly J; Van Wier Scott A; Ahmann Greg J; Fonseca Rafael
Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy.
Blood 2005;106(8):2837-40.
2005: Nowakowski Grzegorz S; Witzig Thomas E; Dingli David; Tracz Michal J; Gertz Morie A; Lacy Martha Q; Lust John A; Dispenzieri Angela; Greipp Philip R; Kyle Robert A; Rajkumar S Vincent
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma.
Blood 2005;106(7):2276-9.
2005: Yoong Yinlee; Porrata Luis F; Inwards David J; Ansell Stephen M; Micallef Ivana N M; Litzow Mark R; Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Gastineau Dennis A; Tefferi Ayalew; Elliott Michelle; Snow Denis S; Hogan Willian J; Markovic Svetomir N
The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma.
Leukemia & lymphoma 2005;46(9):1287-94.
2005: Chng Wee Joo; Van Wier Scott A; Ahmann Gregory J; Winkler Jerry M; Jalal Syed M; Bergsagel Peter Leif; Chesi Marta; Trendle Mike C; Oken Martin M; Blood Emily; Henderson Kim; Santana-Dávila Rafael; Kyle Robert A; Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Greipp Philip R; Fonseca Rafael
A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.
Blood 2005;106(6):2156-61.
2005: Leung Nelson; Dispenzieri Angela; Fervenza Fernando C; Lacy Martha Q; Villicana Rafael; Cavalcante Joao L; Gertz Morie A
Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;46(2):270-7.
2005: Kumar Shaji; Rajkumar S Vincent; Kyle Robert A; Lacy Martha Q; Dispenzieri Angela; Fonseca Rafael; Lust John A; Gertz Morie A; Greipp Philip R; Witzig Thomas E
Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5668-74.
2005: Gertz Morie A; Comenzo Ray; Falk Rodney H; Fermand Jean Paul; Hazenberg Bouke P; Hawkins Philip N; Merlini Giampaolo; Moreau Philippe; Ronco Pierre; Sanchorawala Vaishali; Sezer Orhan; Solomon Alan; Grateau Giles
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.
American journal of hematology 2005;79(4):319-28.
2005: Leung Nelson; Griffin Matthew D; Dispenzieri Angela; Haugen Eric N; Gloor James M; Schwab Thomas R; Textor Stephen C; Lacy Martha Q; Litzow Mark R; Cosio Fernando G; Larson Timothy S; Gertz Morie A; Stegall Mark D
Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(7):1660-70.
2005: Palladini Giovanni; Kyle Robert A; Larson Dirk R; Therneau Terry M; Merlini Giampaolo; Gertz Morie A
Multicentre versus single centre approach to rare diseases: the model of systemic light chain amyloidosis.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2005;12(2):120-6.
2005: Dispenzieri Angela; Gertz Morie A
Treatment options for POEMS syndrome.
Expert opinion on pharmacotherapy 2005;6(6):945-53.
2005: Gertz Morie A
Waldenström macroglobulinemia: a review of therapy.
American journal of hematology 2005;79(2):147-57.
2005: Dispenzieri Angela; Gertz Morie A
Treatment of Castleman's disease.
Current treatment options in oncology 2005;6(3):255-66.
2005: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne
Current status of stem cell transplantation for multiple myeloma.
Current treatment options in oncology 2005;6(3):229-40.
2005: Gertz Morie A
Cold agglutinin disease and cryoglobulinemia.
Clinical lymphoma 2005;5(4):290-3.
2005: Gertz Morie A; Geyer Susan M; Badros Ashraf; Kahl Brad S; Erlichman Charles
Early results of a phase I trial of oblimersen sodium for relapsed or refractory Waldenstrom's macroglobulinemia.
Clinical lymphoma 2005;5(4):282-4.
2005: Porrata Luis F; Gertz Morie A; Litzow Mark R; Lacy Martha Q; Dispenzieri Angela; Inwards David J; Ansell Stephen M; Micallef Ivanna N M; Gastineau Dennis A; Elliott Michele; Hogan William J; Hayman Suzanne R; Tefferi Ayalew; Markovic Svetomir N
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1210-8.
2005: Murtagh Blaithnead; Hammill Stephen C; Gertz Morie A; Kyle Robert A; Tajik A Jamil; Grogan Martha
Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement.
The American journal of cardiology 2005;95(4):535-7.
2005: Leung Nelson; Slezak Jeff M; Bergstralh Erik J; Dispenzieri Angela; Lacy Martha Q; Wolf Robert C; Gertz Morie A
Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(1):102-11.
2005: Modesto Karen M; Dispenzieri Angela; Cauduro Sanderson A; Lacy Martha; Khandheria Bijoy K; Pellikka Patricia A; Belohlavek Marek; Seward James B; Kyle Robert; Tajik A Jamil; Gertz Morie; Abraham Theodore P
Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques.
European heart journal 2005;26(2):173-9.
2005: Dispenzieri A; Wiseman G A; Lacy M Q; Litzow M R; Anderson P M; Gastineau D A; Tefferi A; Inwards D J; Micallef I N M; Ansell S M; Porrata L; Elliott M A; Lust J A; Greipp P R; Rajkumar S V; Fonseca R; Witzig T E; Erlichman C; Sloan J A; Gertz M A
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(1):118-25.
2005: Abraham Roshini S; Ballman Karla V; Dispenzieri Angela; Grill Diane E; Manske Michelle K; Price-Troska Tammy L; Paz Natalia Gonzalez; Gertz Morie A; Fonseca Rafael
Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis.
Blood 2005;105(2):794-803.
2005: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R
Amyloidosis.
Best practice & research. Clinical haematology 2005;18(4):709-27.
2004: Murphy Charles L; Wang Shuching; Weaver Kristal; Gertz Morie A; Weiss Deborah T; Solomon Alan
Renal apolipoprotein A-I amyloidosis associated with a novel mutant Leu64Pro.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;44(6):1103-9.
2004: Ghobrial Irene M; Uslan Daniel Z; Call Timothy G; Witzig Thomas E; Gertz Morie A
Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenström macroglobulinemia does not indicate failure of response.
American journal of hematology 2004;77(4):329-30.
2004: Gertz M A; Lacy M Q; Dispenzieri A; Ansell S M; Elliott M A; Gastineau D A; Inwards D J; Micallef I N M; Porrata L F; Tefferi A; Litzow M R
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate.
Bone marrow transplantation 2004;34(12):1025-31.
2004: Ghobrial Irene M; Fonseca Rafael; Greipp Philip R; Blood Emily; Rue Montserrat; Vesole David H; Gertz Morie A;
Initial immunoglobulin M 'flare' after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: an Eastern Cooperative Oncology Group Study.
Cancer 2004;101(11):2593-8.
2004: Dispenzieri Angela; Moreno-Aspitia Alvaro; Suarez Guillermo A; Lacy Martha Q; Colon-Otero Gerardo; Tefferi Ayalew; Litzow Mark R; Roy Vivek; Hogan William J; Kyle Robert A; Gertz Morie A
Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature.
Blood 2004;104(10):3400-7.
2004: Gertz Morie A; Rue Montserrat; Blood Emily; Kaminer Lynne S; Vesole David H; Greipp Philip R
Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98).
Leukemia & lymphoma 2004;45(10):2047-55.
2004: Dispenzieri Angela; Gertz Morie A; Kyle Robert A; Lacy Martha Q; Burritt Mary F; Therneau Terry M; Greipp Philip R; Witzig Thomas E; Lust John A; Rajkumar S Vincent; Fonseca Rafael; Zeldenrust Steven R; McGregor Christopher G A; Jaffe Allan S
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3751-7.
2004: Kumar S; Lacy M Q; Dispenzieri A; Rajkumar S V; Fonseca R; Geyer S; Allmer C; Witzig T E; Lust J A; Greipp P R; Kyle R A; Litzow M R; Gertz M A
Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma.
Bone marrow transplantation 2004;34(6):485-90.
2004: Dispenzieri Angela; Gertz Morie A; Kyle Robert A; Lacy Martha Q; Burritt Mary F; Therneau Terry M; McConnell Joseph P; Litzow Mark R; Gastineau Dennis A; Tefferi Ayalew; Inwards David J; Micallef Ivana N; Ansell Stephen M; Porrata Luis F; Elliott Michelle A; Hogan William J; Rajkumar S Vincent; Fonseca Rafael; Greipp Philip R; Witzig Thomas E; Lust John A; Zeldenrust Steven R; Snow Denise S; Hayman Susan R; McGregor Christopher G A; Jaffe Allan S
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.
Blood 2004;104(6):1881-7.
2004: Ha Jong-Won; Ommen Steve R; Tajik A Jamil; Barnes Marion E; Ammash Naser M; Gertz Morie A; Seward James B; Oh Jae K
Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography.
The American journal of cardiology 2004;94(3):316-9.
2004: Kumar S; Gertz M A; Dispenzieri A; Lacy M Q; Wellik L A; Fonseca R; Lust J A; Witzig T E; Kyle R A; Greipp P R; Rajkumar S V
Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.
Bone marrow transplantation 2004;34(3):235-9.
2004: Kumar Shaji K; Therneau Terry M; Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Rajkumar S Vincent; Fonseca Rafael; Witzig Thomas E; Lust John A; Larson Dirk R; Kyle Robert A; Greipp Philip R
Clinical course of patients with relapsed multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2004;79(7):867-74.
2004: Abraham Roshini S; Geyer Susan M; Ramírez-Alvarado Marina; Price-Troska Tammy L; Gertz Morie A; Fonseca Rafael
Analysis of somatic hypermutation and antigenic selection in the clonal B cell in immunoglobulin light chain amyloidosis (AL).
Journal of clinical immunology 2004;24(4):340-53.
2004: Gertz M A; Blood E; Vesole D H; Abonour R; Lazarus H M; Greipp P R
A multicenter phase 2 trial of stem cell transplantation for immunoglobulin light-chain amyloidosis (E4A97): an Eastern Cooperative Oncology Group Study.
Bone marrow transplantation 2004;34(2):149-54.
2004: Kumar S; Lacy M Q; Dispenzieri A; Rajkumar S V; Fonseca R; Geyer S; Allmer C; Witzig T E; Lust J A; Greipp P R; Kyle R A; Litzow M R; Gertz M A
High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy.
Bone marrow transplantation 2004;34(2):161-7.
2004: Ma Cynthia X; Lacy Martha Q; Rompala John F; Dispenzieri Angela; Rajkumar S Vincent; Greipp Philip R; Fonseca Rafael; Kyle Robert A; Gertz Morie A
Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma.
Blood 2004;104(1):40-2.
2004: Gertz Morie A
The classification and typing of amyloid deposits.
American journal of clinical pathology 2004;121(6):787-9.
2004: Dispenzieri Angela; Gertz Morie A
Treatment of POEMS syndrome.
Current treatment options in oncology 2004;5(3):249-57.
2004: Porrata L F; Gertz M A; Geyer S M; Litzow M R; Gastineau D A; Moore S B; Pineda A A; Bundy K L; Padley D J; Persky D; Lacy M Q; Dispenzieri A; Snow D S; Markovic S N
The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(6):1085-92.
2004: Dispenzieri Angela; Kyle Robert A; Lacy Martha Q; Therneau Terry M; Larson Dirk R; Plevak Matthew F; Rajkumar S Vincent; Fonseca Rafael; Greipp Philip R; Witzig Thomas E; Lust John A; Zeldenrust Steven R; Snow Denise S; Hayman Susan R; Litzow Mark R; Gastineau Dennis A; Tefferi Ayalew; Inwards David J; Micallef Ivana N; Ansell Stephen M; Porrata Luis F; Elliott Michelle A; Gertz Morie A
Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study.
Blood 2004;103(10):3960-3.
2004: Kumar S; Witzig T E; Dispenzieri A; Lacy M Q; Wellik L E; Fonseca R; Lust J A; Gertz M A; Kyle R A; Greipp P R; Rajkumar S V
Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(3):624-7.
2004: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela
Therapy for immunoglobulin light chain amyloidosis: the new and the old.
Blood reviews 2004;18(1):17-37.
2004: Leung Nelson; Lager Donna J; Gertz Morie A; Wilson Kirk; Kanakiriya Sharan; Fervenza Fernando C
Long-term outcome of renal transplantation in light-chain deposition disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(1):147-53.
2004: Gertz Morie A; Merlini Giampaolo; Treon Steven P
Amyloidosis and Waldenström's macroglobulinemia.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2004;():257-82.
2003: Dispenzieri Angela; Lacy Martha Q; Rajkumar S Vincent; Geyer Susan M; Witzig Thomas E; Fonseca Rafael; Lust John A; Greipp Philip R; Kyle Robert A; Gertz Morie A
Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2003;10(4):257-61.
2003: Reece D E; Bredeson C; Pérez W S; Jagannath S; Zhang M J; Ballen K K; Elfenbein G J; Freytes C O; Gale R P; Gertz M A; Gibson J; Giralt S A; Keating A; Kyle R A; Maharaj D; Marcellus D; McCarthy P L; Milone G A; Nimer S D; Pavlovsky S; To L B; Weisdorf D J; Wiernik P H; Wingard J R; Vesole D H
Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age.
Bone marrow transplantation 2003;32(12):1135-43.
2003: Gertz Morie
Transplantation for multiple myeloma. Pertinent Questions.
Blood 2003;102(10):3472-5.
2003: Ghobrial Irene M; Gertz Morie A; Fonseca Rafael
Waldenström macroglobulinaemia.
The lancet oncology 2003;4(11):679-85.
2003: Fonseca Rafael; Debes-Marun Carina S; Picken Elisa B; Dewald Gordon W; Bryant Sandra C; Winkler Jerry M; Blood Emily; Oken Martin M; Santana-Dávila Rafael; González-Paz Natalia; Kyle Robert A; Gertz Morie A; Dispenzieri Angela; Lacy Martha Q; Greipp Philip R
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma.
Blood 2003;102(7):2562-7.
2003: Park Miguel A; Mueller Paul S; Kyle Robert A; Larson Dirk R; Plevak Matthew F; Gertz Morie A
Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients.
Medicine 2003;82(5):291-8.
2003: Kumar S; Chen M G; Gastineau D A; Gertz M A; Inwards D J; Lacy M Q; Tefferi A; Litzow M R
Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(9):1865-70.
2003: Ghobrial I M; Dispenzieri A; Bundy K L; Gastineau D A; Rajkumar S V; Therneau T M; Lacy M Q; Witzig T E; Litzow M R; Christensen B R; Hayman S; Pribula C G; Gertz M A
Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma.
Bone marrow transplantation 2003;32(6):587-92.
2003: Howe R; Micallef I N M; Inwards D J; Ansell S M; Dewald G W; Dispenzieri A; Gastineau D A; Gertz M A; Geyer S M; Hanson C A; Lacy M Q; Tefferi A; Litzow M R
Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma.
Bone marrow transplantation 2003;32(3):317-24.
2003: Dispenzieri Angela; Kyle Robert A; Gertz Morie A; Therneau Terry M; Miller Wayne L; Chandrasekaran Krishnaswamy; McConnell Joseph P; Burritt Mary F; Jaffe Allan S
Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins.
Lancet 2003;361(9371):1787-9.
2003: Gertz Morie A; Bauer Brent A
Caring (really) for patients who use alternative therapies for cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9 Suppl):125s-128s.
2003: Abraham Roshini S; Geyer Susan M; Price-Troska Tammy L; Allmer Cristine; Kyle Robert A; Gertz Morie A; Fonseca Rafael
Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL).
Blood 2003;101(10):3801-8.
2003: Gertz Morie A; Kyle Robert A
Amyloidosis with IgM monoclonal gammopathies.
Seminars in oncology 2003;30(2):325-8.
2003: Dhodapkar Madhav V; Jacobson Joth L; Gertz Morie A; Crowley John J; Barlogie Bart
Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: an update of a US intergroup trial (SW0G S9003).
Seminars in oncology 2003;30(2):220-5.
2003: Gertz Morie A; Anagnostopoulos Athanasios; Anderson Kenneth; Branagan Andrew R; Coleman Morton; Frankel Stanley R; Giralt Sergio; Levine Todd; Munshi Nikhil; Pestronk Alan; Rajkumar Vincent; Treon Steven P
Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Seminars in oncology 2003;30(2):121-6.
2003: Elliott Michelle A; Nichols William L; Plumhoff Elizabeth A; Ansell Stephen M; Dispenzieri Angela; Gastineau Dennis A; Gertz Morie A; Inwards David J; Lacy Martha Q; Micallef Ivana N M; Tefferi Ayalew; Litzow Mark
Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review.
Mayo Clinic proceedings. Mayo Clinic 2003;78(4):421-30.
2003: Rajkumar S V; Gertz M A; Lacy M Q; Dispenzieri A; Fonseca R; Geyer S M; Iturria N; Kumar S; Lust J A; Kyle R A; Greipp P R; Witzig T E
Thalidomide as initial therapy for early-stage myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(4):775-9.
2003: Dispenzieri Angela; Kyle Robert A; Lacy Martha Q; Rajkumar S Vincent; Therneau Terry M; Larson Dirk R; Greipp Philip R; Witzig Thomas E; Basu Rita; Suarez Guillermo A; Fonseca Rafael; Lust John A; Gertz Morie A
POEMS syndrome: definitions and long-term outcome.
Blood 2003;101(7):2496-506.
2003: Kyle Robert A; Gertz Morie A; Lacy Martha Q; Dispenzieri Angela
Localized AL amyloidosis of the colon: an unrecognized entity.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2003;10(1):36-41.
2003: Kumar Shaji; Fonseca Rafael; Dispenzieri Angela; Lacy Martha Q; Lust John A; Wellik Linda; Witzig Thomas E; Gertz Morie A; Kyle Robert A; Greipp Philip R; Rajkumar S Vincent
Prognostic value of angiogenesis in solitary bone plasmacytoma.
Blood 2003;101(5):1715-7.
2003: Debes-Marun C S; Dewald G W; Bryant S; Picken E; Santana-Dávila R; González-Paz N; Winkler J M; Kyle R A; Gertz M A; Witzig T E; Dispenzieri A; Lacy M Q; Rajkumar S V; Lust J A; Greipp P R; Fonseca R
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(2):427-36.
2003: Abraham Roshini S; Katzmann Jerry A; Clark Raynell J; Bradwell A R; Kyle Robert A; Gertz Morie A
Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis.
American journal of clinical pathology 2003;119(2):274-8.
2003: Pardanani Animesh; Witzig Thomas E; Schroeder Georgene; McElroy Edwin A; Fonseca Rafael; Dispenzieri Angela; Lacy Martha Q; Lust John A; Kyle Robert A; Greipp Philip R; Gertz Morie A; Rajkumar S Vincent
Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis.
Blood 2003;101(3):827-30.
2003: Kumar Shaji; Gertz Morie A; Dispenzieri Angela; Lacy Martha Q; Geyer Susan M; Iturria Nancy L; Fonseca Rafael; Hayman Suzanne R; Lust John A; Kyle Robert A; Greipp Philip R; Witzig Thomas E; Rajkumar S Vincent
Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2003;78(1):34-9.
2003: Kyle Robert A; Gertz Morie A; Witzig Thomas E; Lust John A; Lacy Martha Q; Dispenzieri Angela; Fonseca Rafael; Rajkumar S Vincent; Offord Janice R; Larson Dirk R; Plevak Matthew E; Therneau Terry M; Greipp Philip R
Review of 1027 patients with newly diagnosed multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2003;78(1):21-33.
2002: Rajkumar S Vincent; Kyle Robert A; Gertz Morie A
Myeloma and the newly diagnosed patient: a focus on treatment and management.
Seminars in oncology 2002;29(6 Suppl 17):5-10.
2002: Gertz Morie A
Diagnosing primary amyloidosis.
Mayo Clinic proceedings. Mayo Clinic 2002;77(12):1278-9.
2002: Kumar Shaji; Fonseca Rafael; Dispenzieri Angela; Lacy Martha Q; Lust John A; Witzig Thomas E; Gertz Morie A; Kyle Robert A; Greipp Philip R; Rajkumar S Vincent
Bone marrow angiogenesis in multiple myeloma: effect of therapy.
British journal of haematology 2002;119(3):665-71.
2002: Litzow Mark R; Repoussis Panagiotis D; Schroeder Georgene; Schembri-Wismayer David; Batts Kenneth P; Anderson Peter M; Arndt Carola A S; Chen Michael G; Gastineau Dennis A; Gertz Morie A; Inwards David J; Lacy Martha Q; Tefferi Ayalew; Noël Pierre; Solberg Lawrence A; Letendre Louis; Hoagland H Clark
Veno-occlusive disease of the liver after blood and marrow transplantation: analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator.
Leukemia & lymphoma 2002;43(11):2099-107.
2002: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Gastineau Dennis A; Chen Michael G; Ansell Stephen M; Inwards David J; Micallef Ivana N M; Tefferi Ayalew; Litzow Mark R
Stem cell transplantation for the management of primary systemic amyloidosis.
The American journal of medicine 2002;113(7):549-55.
2002: Rajkumar S Vincent; Hayman Suzanne; Gertz Morie A; Dispenzieri Angela; Lacy Martha Q; Greipp Philip R; Geyer Susan; Iturria Nancy; Fonseca Rafael; Lust John A; Kyle Robert A; Witzig Thomas E
Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(21):4319-23.
2002: Malek Reza S; Wahner-Roedler Dietlind L; Gertz Morie A; Kyle Robert A
Primary localized amyloidosis of the bladder: experience with dimethyl sulfoxide therapy.
The Journal of urology 2002;168(3):1018-20.
2002: Gertz Morie A
Waldenström's macroglobulinemia: a review of therapy.
Leukemia & lymphoma 2002;43(8):1517-26.
2002: Kumar S; Wolf R C; Chen M G; Gastineau D A; Gertz M A; Inwards D J; Lacy M Q; Tefferi A; Litzow M R
Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease.
Bone marrow transplantation 2002;30(3):161-5.
2002: Rajkumar S Vincent; Gertz Morie A; Kyle Robert A; Greipp Philip R;
Current therapy for multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2002;77(8):813-22.
2002: Fonseca Rafael; Bailey Richard J; Ahmann Gregory J; Rajkumar S Vincent; Hoyer James D; Lust John A; Kyle Robert A; Gertz Morie A; Greipp Philip R; Dewald Gordon W
Genomic abnormalities in monoclonal gammopathy of undetermined significance.
Blood 2002;100(4):1417-24.
2002: Rajkumar S Vincent; Mesa Ruben A; Fonseca Rafael; Schroeder Georgene; Plevak Matthew F; Dispenzieri Angela; Lacy Martha Q; Lust John A; Witzig Thomas E; Gertz Morie A; Kyle Robert A; Russell Stephen J; Greipp Philip R
Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2210-6.
2002: Gertz Morie A; Rajkumar S Vincent
Primary systemic amyloidosis.
Current treatment options in oncology 2002;3(3):261-71.
2002: Mueller Paul S; Terrell Christine L; Gertz Morie A
Fever of unknown origin caused by multiple myeloma: a report of 9 cases.
Archives of internal medicine 2002;162(11):1305-9.
2002: Comenzo Raymond L; Gertz Morie A
Autologous stem cell transplantation for primary systemic amyloidosis.
Blood 2002;99(12):4276-82.
2002: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Cheson Bruce D; Barlogie Bart; Kyle Robert A; Palladini Giovanni; Geyer Susan M; Merlini Giampaolo
A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin (IDOX) in primary amyloidosis (AL).
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2002;9(1):24-30.
2002: Donovan K A; Lacy M Q; Gertz M A; Lust J A
IL-1beta expression in IgM monoclonal gammopathy and its relationship to multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(3):382-5.
2002: Schop Roelandt F J; Jalal Syed M; Van Wier Scott A; Ahmann Gregory J; Bailey Richard J; Kyle Robert A; Greipp Philip R; Rajkumar S Vincent; Gertz Morie A; Lust John A; Lacy Martha Q; Dispenzieri Angela; Witzig Thomas E; Fonseca Rafael
Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression.
Cancer genetics and cytogenetics 2002;132(1):55-60.
2002: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela
Immunoglobulin light chain amyloidosis and the kidney.
Kidney international 2002;61(1):1-9.
2001: Rajkumar S V; Fonseca R; Dispenzieri A; Lacy M Q; Lust J A; Witzig T E; Therneau T M; Kyle R A; Greipp P R; Gertz M A
Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantation.
American journal of hematology 2001;68(4):269-75.
2001: Gertz M A; Bauer B A
Caring (really) for patients who use alternative therapies for cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(23):4346-9.
2001: Kumar S; Chen M G; Gastineau D A; Gertz M A; Inwards D J; Lacy M Q; Tefferi A; Litzow M R
Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia.
Bone marrow transplantation 2001;28(10):951-6.
2001: Hayman S R; Lacy M Q; Kyle R A; Gertz M A
Primary systemic amyloidosis: a cause of malabsorption syndrome.
The American journal of medicine 2001;111(7):535-40.
2001: Hayman S R; Bailey R J; Jalal S M; Ahmann G J; Dispenzieri A; Gertz M A; Greipp P R; Kyle R A; Lacy M Q; Rajkumar S V; Witzig T E; Lust J A; Fonseca R
Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis.
Blood 2001;98(7):2266-8.
2001: Kumar S; Dispenzieri A; Lacy M Q; Litzow M R; Gertz M A
High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis.
Bone marrow transplantation 2001;28(4):381-5.
2001: Hogan W J; Lacy M Q; Wiseman G A; Fealey R D; Dispenzieri A; Gertz M A
Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation.
Bone marrow transplantation 2001;28(3):305-9.
2001: Rajkumar S V; Dispenzieri A; Fonseca R; Lacy M Q; Geyer S; Lust J A; Kyle R A; Greipp P R; Gertz M A; Witzig T E
Thalidomide for previously untreated indolent or smoldering multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(8):1274-6.
2001: Porrata L F; Gertz M A; Inwards D J; Litzow M R; Lacy M Q; Tefferi A; Gastineau D A; Dispenzieri A; Ansell S M; Micallef I N; Geyer S M; Markovic S N
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma.
Blood 2001;98(3):579-85.
2001: Dispenzieri A; Lacy M Q; Kyle R A; Therneau T M; Larson D R; Rajkumar S V; Fonseca R; Greipp P R; Witzig T E; Lust J A; Gertz M A
Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(14):3350-6.
2001: Dhodapkar M V; Jacobson J L; Gertz M A; Rivkin S E; Roodman G D; Tuscano J M; Shurafa M; Kyle R A; Crowley J J; Barlogie B
Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003).
Blood 2001;98(1):41-8.
2001: Kumar S; Chen M G; Gastineau D A; Gertz M A; Inwards D J; Lacy M Q; Tefferi A; Harmsen W S; Litzow M R
Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease.
Bone marrow transplantation 2001;27(11):1133-40.
2001: Dispenzieri A; Gertz M A; Therneau T M; Kyle R A
Retrospective cohort study of 148 patients with polyclonal gammopathy.
Mayo Clinic proceedings. Mayo Clinic 2001;76(5):476-87.
2001: Steensma D P; Gertz M A; Greipp P R; Kyle R A; Lacy M Q; Lust J A; Offord J R; Plevak M F; Therneau T M; Witzig T E
A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death.
Blood 2001;97(8):2522-3.
2000: Rajkumar S V; Fonseca R; Dispenzieri A; Lacy M Q; Witzig T E; Lust J A; Larson D; Therneau T M; Kyle R A; Litzow M R; Greipp P R; Gertz M A
Effect of complete response on outcome following autologous stem cell transplantation for myeloma.
Bone marrow transplantation 2000;26(9):979-83.
2000: Gertz M A; Lacy M Q; Gastineau D A; Inwards D J; Chen M G; Tefferi A; Kyle R A; Litzow M R
Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL).
Bone marrow transplantation 2000;26(9):963-9.
2000: Fonseca R; Rajkumar S V; Ahmann G J; Jalal S M; Hoyer J D; Gertz M A; Kyle R A; Greipp P R; Dewald G W
Fish demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosis.
Leukemia & lymphoma 2000;39(3-4):391-5.
2000: Rajkumar S V; Fonseca R; Dispenzieri A; Lacy M Q; Lust J A; Witzig T E; Kyle R A; Gertz M A; Greipp P R
Thalidomide in the treatment of relapsed multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2000;75(9):897-901.
2000: Mueller P S; Edwards W D; Gertz M A
Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis.
The American journal of medicine 2000;109(3):181-8.
2000: Rajkumar S V; Leong T; Roche P C; Fonseca R; Dispenzieri A; Lacy M Q; Lust J A; Witzig T E; Kyle R A; Gertz M A; Greipp P R
Prognostic value of bone marrow angiogenesis in multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3111-6.
2000: Gertz M A; Lacy M Q; Inwards D J; Gastineau D A; Tefferi A; Chen M G; Witzig T E; Greipp P R; Litzow M R
Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma.
Bone marrow transplantation 2000;26(1):45-50.
2000: Grogan M; Gertz M A; Kyle R A; Tajik A J
Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement.
The American journal of cardiology 2000;85(5):664-5, A11.
2000: Kyle R A; Greipp P R; Gertz M A; Witzig T E; Lust J A; Lacy M Q; Therneau T M
Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil.
British journal of haematology 2000;108(4):737-42.
2000: Gertz M A; Lacy M Q; Dispenzieri A
Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report.
Bone marrow transplantation 2000;25(5):465-70.
2000: Clements I P; Olson L J; Scanlon P D; Gertz M A; Mullany C J
The effect of respiration on left ventricular diastolic filling as assessed by radionuclide ventriculography.
Nuclear medicine communications 2000;21(1):55-63.
2000: Gertz M A; Fonseca R; Rajkumar S V
Waldenström's macroglobulinemia.
The oncologist 2000;5(1):63-7.
1999: Lacy M Q; Gertz M A
Acquired Fanconi's syndrome associated with monoclonal gammopathies.
Hematology/oncology clinics of North America 1999;13(6):1273-80.
1999: Gertz M A; Lacy M Q; Dispenzieri A
Amyloidosis.
Hematology/oncology clinics of North America 1999;13(6):1211-33, ix.
1999: Al Suwaidi J; Velianou J L; Gertz M A; Cannon R O; Higano S T; Holmes D R; Lerman A
Systemic amyloidosis presenting with angina pectoris.
Annals of internal medicine 1999;131(11):838-41.
1999: Fonseca R; Hoyer J D; Aguayo P; Jalal S M; Ahmann G J; Rajkumar S V; Witzig T E; Lacy M Q; Dispenzieri A; Gertz M A; Kyle R A; Greipp P R
Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma.
Leukemia & lymphoma 1999;35(5-6):599-605.
1999: Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
Bone marrow transplantation 1999;24(5):497-503.
1999: Rajkumar S V; Fonseca R; Dewald G W; Therneau T M; Lacy M Q; Kyle R A; Greipp P R; Gertz M A
Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma.
Cancer genetics and cytogenetics 1999;113(1):73-7.
1999: Rajkumar S V; Fonseca R; Lacy M Q; Witzig T E; Lust J A; Greipp P R; Therneau T M; Kyle R A; Litzow M R; Gertz M A
Autologous stem cell transplantation for relapsed and primary refractory myeloma.
Bone marrow transplantation 1999;23(12):1267-72.
1999: Rajkumar S V; Fonseca R; Lacy M Q; Witzig T E; Lust J A; Greipp P R; Therneau T M; Kyle R A; Litzow M R; Gertz M A
Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma.
Bone marrow transplantation 1999;23(12):1261-6.
1999: Gertz M A; Lacy M Q; Lust J A; Greipp P R; Witzig T E; Kyle R A
Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis.
American journal of hematology 1999;61(2):115-9.
1999: Rajkumar S V; Fonseca R; Lacy M Q; Witzig T E; Therneau T M; Kyle R A; Litzow M R; Gertz M A; Greipp P R
Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1551-7.
1999: Gertz M A; Lacy M Q; Dispenzieri A
Amyloidosis: recognition, confirmation, prognosis, and therapy.
Mayo Clinic proceedings. Mayo Clinic 1999;74(5):490-4.
1999: Rajkumar S V; Fonseca R; Witzig T E; Gertz M A; Greipp P R
Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(3):469-72.
1999: Gertz M A; Lacy M Q; Inwards D J; Chen M G; Pineda A A; Gastineau D A; Greipp P R; Lust J A; Tefferi A; Witzig T E; Kyle R A; Litzow M R
Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
Bone marrow transplantation 1999;23(3):221-6.
1999: Kyle R A; Gertz M A; Greipp P R; Witzig T E; Lust J A; Lacy M Q; Therneau T M
Long-term survival (10 years or more) in 30 patients with primary amyloidosis.
Blood 1999;93(3):1062-6.
1999: Gertz M A; Lacy M Q; Lust J A; Greipp P R; Witzig T E; Kyle R A
Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):262-7.
1998: Fonseca R; Ahmann G J; Jalal S M; Dewald G W; Larson D R; Therneau T M; Gertz M A; Kyle R A; Greipp P R
Chromosomal abnormalities in systemic amyloidosis.
British journal of haematology 1998;103(3):704-10.
1998: Fonseca R; Witzig T E; Gertz M A; Kyle R A; Hoyer J D; Jalal S M; Greipp P R
Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 cases.
British journal of haematology 1998;101(2):296-301.
1998: Rajkumar S V; Gertz M A; Kyle R A
Primary systemic amyloidosis with delayed progression to multiple myeloma.
Cancer 1998;82(8):1501-5.
1998: Rajkumar S V; Gertz M A; Kyle R A
Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy.
The American journal of medicine 1998;104(3):232-7.
1998: Palmas A; Tefferi A; Myers J L; Scott J P; Swensen S J; Chen M G; Gastineau D A; Gertz M A; Inwards D J; Lacy M Q; Litzow M R
Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation.
British journal of haematology 1998;100(4):680-7.
1998: McElroy E A; Witzig T E; Gertz M A; Greipp P R; Kyle R A
Detection of monoclonal plasma cells in the peripheral blood of patients with primary amyloidosis.
British journal of haematology 1998;100(2):326-7.
1997: Mathew V; Olson L J; Gertz M A; Hayes D L
Symptomatic conduction system disease in cardiac amyloidosis.
The American journal of cardiology 1997;80(11):1491-2.
1997: Lacy M Q; Gertz M A; Hanson C A; Inwards D J; Kyle R A
Multiple myeloma associated with diffuse osteosclerotic bone lesions: a clinical entity distinct from osteosclerotic myeloma (POEMS syndrome).
American journal of hematology 1997;56(4):288-93.
1997: Gertz M A; Lacy M Q; Inwards D J; Pineda A A; Chen M G; Gastineau D A; Tefferi A; Kyle R A; Litzow M R
Factors influencing platelet recovery after blood cell transplantation in multiple myeloma.
Bone marrow transplantation 1997;20(5):375-80.
1997: Gertz M A; Grogan M; Kyle R A; Tajik A J
Endomyocardial biopsy-proven light chain amyloidosis (AL) without echocardiographic features of infiltrative cardiomyopathy.
The American journal of cardiology 1997;80(1):93-5.
1997: Kyle R A; Gertz M A; Greipp P R; Witzig T E; Lust J A; Lacy M Q; Therneau T M
A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.
The New England journal of medicine 1997;336(17):1202-7.
1997: Gertz M A; Witzig T E; Pineda A A; Greipp P R; Kyle R A; Litzow M R
Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation.
Bone marrow transplantation 1997;19(4):337-42.
1996: Kyle R A; Spittell P C; Gertz M A; Li C Y; Edwards W D; Olson L J; Thibodeau S N
The premortem recognition of systemic senile amyloidosis with cardiac involvement.
The American journal of medicine 1996;101(4):395-400.
1996: Witzig T E; Gertz M A; Lust J A; Kyle R A; O'Fallon W M; Greipp P R
Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma.
Blood 1996;88(5):1780-7.
1995: Gertz M A; Garton J P; Greipp P R; Witzig T E; Kyle R A
A phase II study of high-dose methylprednisolone in refractory or relapsed multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(12):2115-8.
1995: Witzig T E; Gertz M A; Lust J A; Kyle R A; Greipp P R
Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest?
Leukemia & lymphoma 1995;19(5-6):417-22.
1995: Garton J P; Gertz M A; Witzig T E; Greipp P R; Lust J A; Schroeder G; Kyle R A
Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial.
Archives of internal medicine 1995;155(19):2069-74.
1995: Gertz M A; Pineda A A; Chen M G; Letendre L; Greipp P R; Solberg L A; Witzig T E; Garton J P; Inwards D J; Litzow M R
Refractory and relapsing multiple myeloma treated by blood stem cell transplantation.
The American journal of the medical sciences 1995;309(3):152-61.
1995: Witzig T E; Gertz M A; Pineda A A; Kyle R A; Greipp P R
Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma.
British journal of haematology 1995;89(3):640-2.
1994: Gertz M A; Kyle R A
Amyloidosis: prognosis and treatment.
Seminars in arthritis and rheumatism 1994;24(2):124-38.
1994: Dhodapkar M; Goldberg S L; Tefferi A; Gertz M A
Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion.
American journal of hematology 1994;45(2):187-8.
1993: Gertz M A; Noël P; Kyle R A
Second malignancies after chemotherapy and transplantation.
Critical reviews in oncology/hematology 1993;14(2):107-25.
1992: Gertz M A
Secondary amyloidosis (AA).
Journal of internal medicine 1992;232(6):517-8.
1992: Kyle R A; Linos A; Beard C M; Linke R P; Gertz M A; O'Fallon W M; Kurland L T
Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989.
Blood 1992;79(7):1817-22.
1992: Letendre L; Hoagland H C; Gertz M A
Hemorrhagic cystitis complicating bone marrow transplantation.
Mayo Clinic proceedings. Mayo Clinic 1992;67(2):128-30.
1992: Letendre L; Hoagland H C; Moore S B; Chen M G; Gastineau D A; Gertz M A; Habermann T M; Litzow M R; Noël P; Solberg L A
Mayo Clinic experience with allogeneic and syngeneic bone marrow transplantation, 1982 through 1990.
Mayo Clinic proceedings. Mayo Clinic 1992;67(2):109-16.
1991: Gastineau D A; Gertz M A; Rosen C B; Kyle R A
Computed tomography for diagnosis of hepatic rupture in primary systemic amyloidosis.
American journal of hematology 1991;37(3):194-6.
1991: Gastineau D A; Gertz M A; Daniels T M; Kyle R A; Bowie E J
Inhibitor of the thrombin time in systemic amyloidosis: a common coagulation abnormality.
Blood 1991;77(12):2637-40.
1988: Gertz M A; Li C Y; Shirahama T; Kyle R A
Utility of subcutaneous fat aspiration for the diagnosis of systemic amyloidosis (immunoglobulin light chain).
Archives of internal medicine 1988;148(4):929-33.
1987: Gertz M A; Petitt R M; Perrault J; Kyle R A
Autosomal dominant familial Mediterranean fever-like syndrome with amyloidosis.
Mayo Clinic proceedings. Mayo Clinic 1987;62(12):1095-100.
1986: Gertz M A; Garton J P; Kyle R A
Primary amyloidosis (AL) in families.
American journal of hematology 1986;22(2):193-8.
1986: Gertz M A; Garton J P; Jennings W H
Aplastic anemia due to tocainide.
The New England journal of medicine 1986;314(9):583-4.
1985: Kyle R A; Greipp P R; Garton J P; Gertz M A
Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine.
The American journal of medicine 1985;79(6):708-16.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Morie Gertz

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Anatomy

Physiology

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Morie Gertz (preview)

All Publications